Cited 0 times in Scipus Cited Count

Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes

DC Field Value Language
dc.contributor.authorLee, SH-
dc.contributor.authorYim, SY-
dc.contributor.authorJeong, YS-
dc.contributor.authorLi, QX-
dc.contributor.authorKang, SH-
dc.contributor.authorSohn, BH-
dc.contributor.authorKumar, SV-
dc.contributor.authorShin, JH-
dc.contributor.authorChoi, YR-
dc.contributor.authorShim, JJ-
dc.contributor.authorKim, H-
dc.contributor.authorKim, JH-
dc.contributor.authorKim, S-
dc.contributor.authorGuo, S-
dc.contributor.authorJohnson, RL-
dc.contributor.authorKaseb, A-
dc.contributor.authorKang, KJ-
dc.contributor.authorChun, YS-
dc.contributor.authorJang, HJ-
dc.contributor.authorLee, BG-
dc.contributor.authorWoo, HG-
dc.contributor.authorHa, MJ-
dc.contributor.authorAkbani, R-
dc.contributor.authorRoberts, LR-
dc.contributor.authorWheeler, DA-
dc.contributor.authorLee, JS-
dc.date.accessioned2023-02-13T06:23:06Z-
dc.date.available2023-02-13T06:23:06Z-
dc.date.issued2022-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/24492-
dc.description.abstractBACKGROUND AND AIMS: Although many studies revealed transcriptomic subtypes of HCC, concordance of the subtypes are not fully examined. We aim to examine a consensus of transcriptomic subtypes and correlate them with clinical outcomes. APPROACH AND RESULTS: By integrating 16 previously established genomic signatures for HCC subtypes, we identified five clinically and molecularly distinct consensus subtypes. STM (STeM) is characterized by high stem cell features, vascular invasion, and poor prognosis. CIN (Chromosomal INstability) has moderate stem cell features, but high genomic instability and low immune activity. IMH (IMmune High) is characterized by high immune activity. BCM (Beta-Catenin with high Male predominance) is characterized by prominent beta-catenin activation, low miRNA expression, hypomethylation, and high sensitivity to sorafenib. DLP (Differentiated and Low Proliferation) is differentiated with high hepatocyte nuclear factor 4A activity. We also developed and validated a robust predictor of consensus subtype with 100 genes and demonstrated that five subtypes were well conserved in patient-derived xenograft models and cell lines. By analyzing serum proteomic data from the same patients, we further identified potential serum biomarkers that can stratify patients into subtypes. CONCLUSIONS: Five HCC subtypes are correlated with genomic phenotypes and clinical outcomes and highly conserved in preclinical models, providing a framework for selecting the most appropriate models for preclinical studies.-
dc.language.isoen-
dc.subject.MESHCarcinoma, Hepatocellular-
dc.subject.MESHConsensus-
dc.subject.MESHFemale-
dc.subject.MESHGenomics-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms-
dc.subject.MESHMale-
dc.subject.MESHPhenotype-
dc.subject.MESHProteomics-
dc.titleConsensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes-
dc.typeArticle-
dc.identifier.pmid35349735-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519807-
dc.contributor.affiliatedAuthorWoo, HG-
dc.type.localJournal Papers-
dc.identifier.doi10.1002/hep.32490-
dc.citation.titleHepatology (Baltimore, Md.)-
dc.citation.volume76-
dc.citation.number6-
dc.citation.date2022-
dc.citation.startPage1634-
dc.citation.endPage1648-
dc.identifier.bibliographicCitationHepatology (Baltimore, Md.), 76(6). : 1634-1648, 2022-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1527-3350-
dc.relation.journalidJ002709139-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse